Business
Citi slaps buy rating on ResMed shares
Image source: Getty Images
ResMed Inc (ASX: RMD) shares are in the red so far in 2025.
After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.
This brings the stock back to its September 2024 levels.
With shares at these…
Continue Reading
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General22 hours agoRed tape on chopping block in bid to build homes faster
-
Noosa News24 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich